Fosun International Limited (FOSUF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Fosun International Limited (FOSUF) trades at $0.43 with AI Score 47/100 (Grade C). Fosun International Limited is a global conglomerate with diverse holdings across health, happiness, wealth creation, and intelligent manufacturing, operating extensively in Mainland China, Portugal, and other international markets. Market cap: $3.50B, Sector: Industrials.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for FOSUF: FOSUF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates FOSUF against Industrials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
FOSUF: the 1 perspectives are evenly split.
How is this calculated? →Fosun International Limited (FOSUF) Industrial Operations Profile
Fosun International Limited is a global conglomerate headquartered in Shanghai, China, with extensive operations in health, happiness, wealth, and intelligent manufacturing across multiple geographies. The company leverages a diversified portfolio spanning pharmaceuticals, tourism, insurance, and industrial production, aiming for long-term value creation through strategic investments and operational management.
What Is the Investment Thesis for FOSUF?
Fosun International Limited (FOSUF) presents an investment profile characterized by its highly diversified conglomerate structure, offering exposure to multiple global sectors including health, happiness, wealth, and intelligent manufacturing. With a market capitalization of $3.50B, the company's broad operational footprint across Mainland China, Portugal, and other international territories provides a degree of geographic and sectoral resilience. Key value drivers include the potential for growth within its integrated Health division, which spans R&D to sales, and the recovery and expansion opportunities within its Happiness segment, encompassing tourism and lifestyle. However, the company currently faces profitability challenges, evidenced by a profit margin of -13.5%, alongside a gross margin of 27.6%. Its beta of 0.46 suggests lower volatility relative to the broader market. The complexity inherent in managing such a diverse portfolio, coupled with international regulatory and operational risks, represents an ongoing challenge. Investors monitor the performance of its key segments and global economic conditions, alongside its modest dividend yield of 0.50%.
Based on FMP financials and quantitative analysis
FOSUF Key Highlights
- Market Capitalization: $3.50 billion, positioning Fosun as a mid-cap global conglomerate.
- Profit Margin: -13.5%, indicating the company is currently operating at a loss.
- Gross Margin: 27.6%, reflecting the profitability of its core sales after accounting for cost of goods sold.
- Beta: 0.46, suggesting the stock exhibits lower volatility compared to the overall market.
- Dividend Yield: 0.50%, providing a modest income return to shareholders.
Who Are FOSUF's Competitors?
FOSUF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| SZHFF Sojitz Corporation | $38.21 | -4.47% | $7.95B | — |
| BJINF Beijing Enterprises Holdings Limited | $3.98 | +0.00% | $5.01B | 39 |
| BDVSY The Bidvest Group Limited | $29.62 | +0.27% | $5.03B | 46 |
| ALFFF Sigma Foods, S.A.B. de C.V. | $1.10 | +29.41% | $6.11B | 52 |
| AYALY Ayala Corporation | $7.52 | +6.26% | $4.68B | 52 |
| CRESY Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria | $11.05 | +0.36% | $716.86M | 64 |
| RSDEF Ramsdens Holdings PLC | $2.39 | +0.00% | $78.15M | 59 |
| MPCFF Metro Pacific Investments Corporation | $0.05 | +0.00% | $1.43B | 58 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are FOSUF's Key Strengths?
- Highly diversified business portfolio across health, happiness, wealth, and intelligent manufacturing sectors.
- Significant global operational presence, including Mainland China, Portugal, and other international markets.
- Integrated value chain within its Health division, from R&D to manufacturing and sales.
- Established strategic investment capabilities across a wide array of industries.
What Are FOSUF's Weaknesses?
- Currently operating with a negative profit margin of -13.5%, indicating unprofitability.
- Complex conglomerate structure can lead to challenges in management, oversight, and achieving synergies.
- Potential for increased regulatory scrutiny across its diverse international operations.
- Reliance on the performance of numerous distinct business units, each with its own market dynamics.
What Could Drive FOSUF Stock Higher?
- Strategic investments across its health, happiness, wealth, and intelligent manufacturing segments, aiming to enhance portfolio value and market presence.
- Expansion of its global operational footprint, particularly in key markets like Mainland China and Portugal, to capture new growth opportunities.
- Development and commercialization of new products and services within its Health division, driving innovation and market share gains.
- Efforts to optimize its diverse conglomerate portfolio through potential asset rebalancing or synergistic acquisitions.
- Recovery and growth in global tourism and leisure sectors, benefiting its Happiness segment investments.
What Are the Key Risks for FOSUF?
- Financial-distress signal — its Altman Z-Score of 0.99 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-22.1%) — the business is not currently generating profit on shareholder capital.
- Negative profit margin of -13.5%, indicating current unprofitability that requires significant operational improvements.
- Complexity of its conglomerate structure and extensive international operations, which could lead to management inefficiencies and regulatory compliance challenges.
- Exposure to adverse global economic conditions, which could impact consumer spending, industrial demand, and investment returns across its diverse holdings.
- Increased regulatory scrutiny or policy changes in Mainland China and other international markets where Fosun operates, affecting business operations and profitability.
- Intense competition across its various business segments, which could pressure margins and limit growth opportunities.
What Are the Growth Opportunities for FOSUF?
- Expansion in Health Division: Fosun's Health division encompasses the full lifecycle of pharmaceutical, biopharmaceutical, and general health products, from R&D to manufacturing, sales, and trade, alongside medical and wellness management services. The global healthcare market is experiencing consistent growth driven by an aging population, rising chronic diseases, and technological advancements. Fosun's integrated approach and international reach provide a strong foundation to expand its market share in key therapeutic areas and medical services, potentially leveraging its R&D capabilities to introduce new products and penetrate emerging health markets. This growth trajectory is ongoing, with long-term potential.
- Growth in Happiness Segment: The Happiness segment, focusing on tourism, leisure, fashion, and lifestyle sectors, stands to benefit significantly from global economic recovery and increasing consumer discretionary spending. As travel restrictions ease and consumer confidence returns, demand for leisure activities, fashion brands, and tourism experiences is projected to rise. Fosun's investments in these areas position it to capture a larger share of this expanding market. Strategic acquisitions and brand development within this segment could drive substantial revenue growth over the next 3-5 years, capitalizing on post-pandemic consumer behavior shifts.
- Strategic Asset Management: Fosun's Asset Management segment oversees asset administration and engages in diverse market investment activities. With global wealth continuing to grow and institutional investors seeking diversified portfolios, there is an ongoing demand for sophisticated asset management services. Fosun's ability to identify and invest in promising ventures across its various ecosystems can generate significant returns. Expanding its client base and offering specialized investment products, particularly in alternative assets or emerging markets, could enhance fee income and investment gains, contributing to stable, long-term growth.
- Intelligent Manufacturing Initiatives: The Intelligent Manufacturing division, active in smart industrial initiatives and the production of iron and steel ore, is well-positioned to benefit from global infrastructure development and industrial modernization trends. The demand for advanced manufacturing solutions and essential industrial materials like iron and steel remains robust, particularly in developing economies and for large-scale urban and industrial projects. Investments in automation, sustainable production methods, and high-value-added products within this division can improve efficiency and market competitiveness, driving revenue growth over the medium term (3-7 years).
- International Market Penetration: Fosun's operations extend across Mainland China, Portugal, and various international territories. Continued strategic expansion into new geographic markets, particularly those with high growth potential or underserved consumer bases, represents a significant growth opportunity. By leveraging its existing global network and diversified business model, Fosun can adapt its health, happiness, wealth, and intelligent manufacturing offerings to local market demands. This ongoing internationalization strategy allows for risk diversification and access to new revenue streams, strengthening its global footprint over the long term.
What Opportunities Does FOSUF Have?
- Continued growth in global healthcare markets driven by demographic shifts and technological advancements.
- Recovery and expansion in the tourism, leisure, and lifestyle sectors post-global events.
- Increased demand for smart industrial solutions and infrastructure development globally.
- Strategic acquisitions and partnerships to further expand its portfolio and geographic reach.
What Threats Does FOSUF Face?
- Adverse global economic downturns impacting consumer spending and industrial demand across its segments.
- Intensified competition within its various operating sectors, potentially eroding market share and margins.
- Changes in regulatory environments and government policies in key operating regions, particularly China.
- Currency fluctuations and geopolitical risks associated with extensive international operations.
What Are FOSUF's Competitive Advantages?
- Highly diversified conglomerate structure provides inherent resilience and reduced reliance on any single industry or market.
- Extensive global operational footprint spanning Mainland China, Portugal, and other international territories, offering broad market access.
- Integrated value chain within its Health division, from R&D to manufacturing and sales, creating efficiencies and control.
- Strategic investment capabilities across multiple high-growth and stable industries, enabling dynamic capital allocation.
What Does FOSUF Do?
Fosun International Limited, established in Shanghai, China, in 1992, operates as a global conglomerate with a broad array of interests, functioning as a subsidiary of Fosun Holdings Limited. The company’s strategic vision centers on creating value across four primary ecosystems: health, happiness, wealth creation, and intelligent manufacturing, with operations spanning Mainland China, Portugal, and various other international territories. Its comprehensive business model is primarily structured around five core divisions. The Health division is vertically integrated, covering the entire lifecycle of pharmaceutical, biopharmaceutical, and general health products, from intensive research and development to manufacturing, sales, and trade, complemented by medical and wellness management services. The Happiness segment is dedicated to investments and operational management within the dynamic tourism, leisure, fashion, and lifestyle sectors, catering to evolving consumer demands. Fosun's Insurance arm focuses on global insurance operations and strategic investments within the sector, leveraging its capital for growth. The Asset Management segment oversees a diverse portfolio of assets and actively engages in various market investment activities, aiming to maximize returns. Lastly, the Intelligent Manufacturing division is at the forefront of smart industrial initiatives and is a significant player in the production of iron and steel ore. Beyond these core divisions, Fosun's extensive scope includes capital investment management, real estate development, retail ventures, reinsurance services, the manufacturing and sale of iron and steel goods, banking and financial services, medical advisory, and the provision of advanced digital solutions, underscoring its multifaceted approach to global business.
What Products and Services Does FOSUF Offer?
- Invests in and operates a diverse portfolio of businesses across health, happiness, wealth, and intelligent manufacturing sectors.
- Conducts research, development, manufacturing, sales, and trade of pharmaceutical and biopharmaceutical products.
- Provides medical and wellness management services.
- Manages and invests in tourism, leisure, fashion, and lifestyle brands and operations.
- Engages in global insurance operations and makes strategic investments within the insurance landscape.
- Oversees asset administration and conducts diverse market investment activities.
- Participates in smart industrial initiatives and produces iron and steel ore.
- Involved in capital investment management, real estate development, retail ventures, reinsurance, banking, and digital solutions.
How Does FOSUF Make Money?
- Generates revenue through the manufacturing and sale of pharmaceutical and biopharmaceutical products, as well as providing medical and wellness services.
- Earns income from operations and investments in its happiness segment, including tourism, leisure, fashion, and lifestyle businesses.
- Derives profits from insurance premiums and investment returns on its global insurance operations.
- Accrues fees and investment gains from its asset management and capital investment activities.
- Generates sales revenue from the production and sale of iron and steel goods and other intelligent manufacturing initiatives.
What Industry Does FOSUF Operate In?
Fosun International Limited operates within the Industrials sector, specifically categorized under Conglomerates, a segment characterized by companies with diverse business interests across multiple industries. This positioning allows Fosun to mitigate risks associated with single-sector reliance but introduces complexity in management and valuation. The competitive landscape for conglomerates is broad, including other diversified global entities that manage extensive portfolios. Fosun differentiates itself through its focus on four key ecosystems: health, happiness, wealth, and intelligent manufacturing, aiming to leverage synergies across these segments. Market trends for conglomerates often involve strategic divestitures and acquisitions to optimize portfolios, alongside navigating varying regulatory environments across international markets. Fosun's global presence, particularly in China and Portugal, positions it to capitalize on regional economic growth and consumer trends.
Who Are FOSUF's Key Customers?
- Healthcare consumers and patients utilizing its pharmaceutical products, biopharmaceuticals, and medical services.
- Global travelers and consumers engaging with its tourism, leisure, fashion, and lifestyle brands.
- Individuals and corporate clients seeking various insurance products and services worldwide.
- High-net-worth individuals, institutional investors, and corporate entities for its asset management and investment services.
- Industrial clients, construction companies, and other manufacturers requiring iron and steel products and smart industrial solutions.
How Fosun International Limited Is Valued
Fosun International Limited carries a market capitalization of $3.50B, placing it in the mid-cap category. Relative to its peer group, FOSUF's quantitative score of 47/100 is roughly in line with the peer average of 47/100.
Company Profile
Fosun International Limited operates in the Conglomerates industry within the Industrials sector. It is headquartered in Shanghai, CN. The company is led by CEO Qiyu Chen. FOSUF has traded publicly since 2010.
ROE -22%Key Financial Metrics
Return on equity for Fosun International Limited stands at -22.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -3.3%, showing how much profit it generates from its asset base. Its free cash flow yield is 57.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.74 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -83.6%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 7/9Financial Health
Fosun International Limited's Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 0.99 places it in the distress zone, a signal of elevated financial risk.
FY2026 estForward Outlook
Wall Street analysts project Fosun International Limited revenue of about $192.00B for fiscal 2026, with EPS near $0.30. The estimate reflects 5 contributing analysts.
FOSUF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Highly diversified business portfolio across health, happiness, wealth, and intelligent manufacturing sectors.
- Significant global operational presence, including Mainland China, Portugal, and other international markets.
- Integrated value chain within its Health division, from R&D to manufacturing and sales.
- Established strategic investment capabilities across a wide array of industries.
Bear Case
- Currently operating with a negative profit margin of -13.5%, indicating unprofitability.
- Complex conglomerate structure can lead to challenges in management, oversight, and achieving synergies.
- Potential for increased regulatory scrutiny across its diverse international operations.
- Reliance on the performance of numerous distinct business units, each with its own market dynamics.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
FOSUF Latest News
No recent news available for FOSUF.
FOSUF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for FOSUF.
Price Targets
Wall Street price target analysis for FOSUF.
FOSUF MoonshotScore
What does this score mean?
The MoonshotScore rates FOSUF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry ConglomeratesLeadership: Qiyu Chen
CEO
Qiyu Chen serves as the CEO of Fosun International Limited, a global conglomerate with a vast operational footprint. In this capacity, he is responsible for managing a substantial workforce of 104,000 employees across the company's diverse business segments. While specific details regarding his educational background and prior career history are not provided in the available data, his leadership role at such a large and complex organization suggests extensive experience in corporate management and strategic oversight within a global context. His position involves navigating the intricacies of Fosun's varied interests, from health and happiness to wealth creation and intelligent manufacturing.
Track Record: Specific achievements and strategic decisions under Qiyu Chen's leadership are not detailed in the provided information. However, his role as CEO of Fosun International Limited, a company established in 1992 and operating globally, implies a track record of guiding the conglomerate through its diverse business ventures. His leadership is central to managing the company's extensive portfolio and its 104,000 employees, influencing its strategic direction across multiple international markets and industries.
FOSUF OTC Market Information
Fosun International Limited trades on the OTC (Over-The-Counter) market under the 'OTC Other' tier. This classification indicates that the company does not meet the listing requirements for the higher OTCQX or OTCQB tiers, which typically have more stringent financial and disclosure standards. Unlike stocks listed on major exchanges like the NYSE or NASDAQ, which have robust listing requirements for market capitalization, share price, and corporate governance, OTC Other companies generally have fewer regulatory obligations. This often translates to less publicly available information and potentially greater risk for investors compared to exchange-listed securities.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Lower liquidity and wider bid-ask spreads compared to major exchanges, potentially impacting trade execution.
- Less stringent disclosure requirements, leading to limited access to comprehensive financial and operational information.
- Increased price volatility due to lower trading volumes and fewer institutional participants.
- Potential for limited analyst coverage and investor awareness, contributing to valuation challenges.
- Regulatory uncertainty and less oversight compared to exchange-listed securities, increasing investment risk.
- Thoroughly review all available financial statements and regulatory filings, if any, to assess financial health.
- Research the company's management team and corporate governance practices.
- Understand the specific business operations and market position of each core division.
- Evaluate the company's global presence and exposure to international economic and political risks.
- Assess the liquidity of the specific OTC ticker (FOSUF) by observing recent trading volumes and bid-ask spreads.
- Verify the legitimacy of the company through independent sources and news coverage.
- Consult with a financial advisor experienced in OTC market investments.
- Established in 1992, indicating a long operational history.
- Operates as a subsidiary of Fosun Holdings Limited, suggesting corporate backing.
- Manages a significant global workforce of 104,000 employees.
- Engages in diverse and tangible business operations across multiple sectors (e.g., pharmaceuticals, manufacturing).
What Investors Ask About Fosun International Limited (FOSUF) — Industrials
What does Fosun International Limited do?
Fosun International Limited is a global conglomerate with a broad portfolio spanning health, happiness, wealth creation, and intelligent manufacturing. Headquartered in Shanghai, China, the company operates through five core divisions: Health (pharmaceuticals, biopharmaceuticals, medical services), Happiness (tourism, leisure, fashion), Insurance (global operations and investments), Asset Management (asset administration, market investments), and Intelligent Manufacturing (smart industrial initiatives, iron and steel production). Its business model involves both direct operations and strategic investments across these diverse sectors, aiming to create value through an integrated ecosystem approach across Mainland China, Portugal, and other international territories.
What are the key financial metrics investors watch for FOSUF?
For FOSUF, investors closely monitor several key financial metrics given its conglomerate nature and OTC listing. The Market Capitalization of $3.50B provides context for its size. The Profit Margin of -13.5% is critical, indicating current unprofitability and signaling a need to assess underlying operational efficiency and cost structures. The Gross Margin of 27.6% offers insight into the profitability of its core sales before overheads. Its Beta of 0.46 suggests lower price volatility relative to the market, which can be a factor for risk assessment. Lastly, the Dividend Yield of 0.50% indicates the current income return to shareholders, though its sustainability is tied to future profitability.
How does Fosun International Limited manage its diverse conglomerate portfolio?
Fosun International Limited manages its diverse conglomerate portfolio by structuring its operations around five distinct yet interconnected core business divisions: Health, Happiness, Insurance, Asset Management, and Intelligent Manufacturing. This divisional structure allows for specialized management within each sector while aiming for synergistic benefits across the broader group. The company employs a strategy of both direct operational management and strategic capital investment, enabling it to adapt to market dynamics in various industries. This approach facilitates resource allocation, risk diversification, and leveraging expertise across its global footprint in Mainland China, Portugal, and other international markets.
What are the key factors to evaluate for FOSUF?
Fosun International Limited (FOSUF) holds an AI score of 47/100 (low). Not financial advice.
How frequently does FOSUF data refresh on this page?
FOSUF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven FOSUF's recent stock price performance?
Fosun International Limited (FOSUF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Highly diversified business portfolio across health, happiness, wealth, and intelligent manufacturing sectors. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider FOSUF overvalued or undervalued right now?
Valuing Fosun International Limited (FOSUF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying FOSUF?
Before investing in Fosun International Limited (FOSUF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- All information is derived directly from the provided source data.
- Specific details on CEO background and track record are limited in the source material.
- OTC market characteristics are inferred based on the 'OTC Other' classification and general market knowledge.